Heart Center, University of Sarajevo Clinics Centre, Bolnicka 25, 71 000, Sarajevo, Bosnia and Herzegovina.
Bosn J Basic Med Sci. 2010 Aug;10(3):218-22. doi: 10.17305/bjbms.2010.2690.
Hypertrophic obstructive cardiomyopathy (HOCM) is a primary, usually familial and genetically fixed myocardial hypertrophy, with dynamic left ventricular outflow tract obstruction. An alternative to surgical myectomy in the treatment of severe, drug refractory, HOCM is percutaneous transluminal septal myocardial ablation (PTSMA). We report a case of 24 year old female patient who had the first septal myectomy but because of progression of her disease, the percutaneous treatment of hypertrophic obstructive cardiomyopathy was performed. A year after the PTSMA the patient was without of symptoms.
肥厚型梗阻性心肌病(HOCM)是一种原发性、通常为家族性和遗传性固定的心肌肥厚,伴有左心室流出道动态梗阻。对于药物难治性严重 HOCM,手术心肌切除术的替代方法是经皮腔内间隔心肌消融术(PTSMA)。我们报告了一例 24 岁女性患者的病例,该患者曾接受过第一次室间隔心肌切除术,但由于疾病进展,随后进行了肥厚型梗阻性心肌病的经皮治疗。在 PTSMA 治疗一年后,患者无症状。